Transaction #17313 · Form 4 · 0001380177-25-000006
Emergent BioSolutions Inc. · Exercise / conversion · Common Stock
Emergent BioSolutions Inc. · Transacted December 5, 2025 · Filed December 9, 2025
What does this filing report?
An SEC Form 4 filing for Emergent BioSolutions Inc. records an exercise / conversion involving Common Stock on December 5, 2025. The reported quantity was 25,748. The filing date is December 9, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- Emergent BioSolutions Inc.
- Company CIK
- 0001367644
- Security type
- Non-derivative
- Acquisition type
- Exercise / conversion · Code M
- Quantity acquired
- 25,748
- Reported price
- 5.02
- Reference value
- 129,254.96
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 124,165
- Ownership description
- Not reported
- SEC acceptance time
- Dec 9, 2025, 6:01 PM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Richard Ronald ↗
Director
CIK 0001380177
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
The linked listing is identified separately from other current company listings.
Filing footnotes & remarks
- F1
- Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated.
- F2
- The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $12.11 to $12.12.
- F3
- Represents shares of common stock sold solely to satisfy the option exercise price and applicable taxes associated with the option exercise.
- F4
- The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $11.88 to $11.97.
- F5
- Consists of stock options granted under the Company's Stock Incentive Plan, as amended and restated, as compensation for Board and Committee service. The shares underlying the options exercised were fully vested on May 22, 2025.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.